These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33690237)

  • 1. Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management.
    Lebbink CA; Waguespack SG; van Santen HM
    Front Horm Res; 2021; 54():140-153. PubMed ID: 33690237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
    van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
    Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study.
    Clement SC; Lebbink CA; Klein Hesselink MS; Teepen JC; Links TP; Ronckers CM; van Santen HM
    Eur J Endocrinol; 2020 Aug; 183(2):169-180. PubMed ID: 32449692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
    Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
    Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer.
    Brignardello E; Felicetti F; Castiglione A; Gallo M; Maletta F; Isolato G; Biasin E; Fagioli F; Corrias A; Palestini N
    Eur J Cancer; 2016 Mar; 55():74-80. PubMed ID: 26775213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study.
    Welch JJG; Ames B; Cohen LE; Gaufberg E; Hudson MM; Nathan PC; Nekhlyudov L; Yock TI; Chemaitilly W; Kenney LB
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29942. PubMed ID: 36069601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Sequelae of Pediatric Cancer Therapy.
    Waguespack SG
    Horm Res Paediatr; 2019; 91(2):104-117. PubMed ID: 30541010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of the thyroid in survivors of childhood Hodgkin's disease.
    Rodriquez DC; Guidoni E; D'ambrosio A; Pochiero F; Caini M; Guglielmucci D; Lucherini M; Carra F; Municchi G
    Minerva Pediatr; 2014 Aug; 66(4):249-56. PubMed ID: 25198559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for subsequent endocrine-related cancer in childhood cancer survivors.
    Wijnen M; van den Heuvel-Eibrink MM; Medici M; Peeters RP; van der Lely AJ; Neggers SJ
    Endocr Relat Cancer; 2016 Jun; 23(6):R299-321. PubMed ID: 27229933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated thyroid cancer following radioiodide 131I therapy of hyperthyroidism--a case report.
    Nĕmec J; Soumar J; Zeman V; Nahodil V; Zamrazil V; Smejkal V
    Oncology; 1978; 35(6):277-80. PubMed ID: 745812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site.
    Davis S; Kopecky KJ; Hamilton TE; Onstad L;
    JAMA; 2004 Dec; 292(21):2600-13. PubMed ID: 15572718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism.
    Granter SR; Cibas ES
    Am J Clin Pathol; 1997 Jan; 107(1):20-5. PubMed ID: 8980362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radionuclide therapy of thyroid disease--radioactive iodine therapy].
    Kusakabe K; Maki M
    Kaku Igaku; 1993 Jul; 30(7):813-9. PubMed ID: 8377305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors.
    van Santen HM; Alexander EK; Rivkees SA; Frey E; Clement SC; Dierselhuis MP; Lebbink CA; Links TP; Lorenz K; Peeters RP; Reiners C; Vriens MR; Nathan P; Schneider AB; Verburg F
    Eur J Endocrinol; 2020 Sep; 183(3):P1-P10. PubMed ID: 32508309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer.
    van Santen HM; Vulsma T; Dijkgraaf MG; Blumer RM; Heinen R; Jaspers MW; Geenen MM; Offringa MO; de Vijlder JJ; van den Bos C
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3657-63. PubMed ID: 12915651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer after exposure to radioactive 131I.
    Holm LE
    Acta Oncol; 2006; 45(8):1037-40. PubMed ID: 17118835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid tumor surveillance using ultrasound in childhood cancer survivors.
    Furui Y; Morita D; Okura E; Komori K; Saito S; Hirabayashi K; Tanaka M; Nakazawa Y
    Pediatr Int; 2020 May; 62(5):562-568. PubMed ID: 32017284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.